Sandison Taylor has filed 5 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 166836 shares of Cidara Therapeutics, Inc. ($CDTX) on September 30, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2024 | Cidara Therapeutics, Inc. | $CDTX | Sandison Taylor | Chief Medical Officer | A | Employee Stock Option (right to buy) | 166836 | $0.00 | 166,836.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2024 | Cidara Therapeutics, Inc. | $CDTX | Sandison Taylor | Chief Medical Officer | S | Common Stock | 924 | $11.64 | 23,067.0000 | 0 | 3.85% | 0.00% |
| March 15, 2024 | Cidara Therapeutics, Inc. | $CDTX | Sandison Taylor | Chief Medical Officer | A | Common Stock | 128750 | $0.00 | 475,845.0000 | 0 | 37.09% | 0.00% |
| March 15, 2024 | Cidara Therapeutics, Inc. | $CDTX | Sandison Taylor | Chief Medical Officer | A | Employee Stock Option (right to buy) | 235500 | $0.00 | 235,500.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2024 | Cidara Therapeutics, Inc. | $CDTX | Sandison Taylor | Chief Medical Officer | S | Common Stock | 20662 | $0.67 | 347,095.0000 | 0 | 5.62% | 0.00% |